SAG
SAG (S-antigen visual arrestin), also known as S-arrestin, S-antigen, ARRESTIN or RP47, is a soluble photoreceptor protein of the arrestin family. It terminates rhodopsin signalling after light activation in rod photoreceptors. Browse Assay Genie's current range of SAG research reagents below, or read on for the biology behind the target.
SAG is involved in the regulation of phototransduction and plays a key role in signal termination after rhodopsin (RHO) has been activated by light in rod photoreceptors. It binds to photoactivated and phosphorylated rhodopsin, which prevents the receptor from interacting with transducin (GNAT1) and so ends transducin-mediated opsin signalling. It may also help to prevent light-dependent degeneration of retinal photoreceptor cells.
The SAG gene encodes S-arrestin, a major soluble photoreceptor protein that belongs to the arrestin family. Members of the arrestin and beta-arrestin family are thought to take part in agonist-mediated desensitisation of G-protein-coupled receptors, dampening cellular responses to stimuli such as hormones, neurotransmitters or sensory signals. S-arrestin is expressed in the retina and the pineal gland, and it inhibits coupling of rhodopsin to transducin in vitro. HGNC places it in the classical arrestins gene group. UniProt records it in the photoreceptor inner segment and the photoreceptor outer segment, as well as in membranes.
The protein was first named S-antigen (retina and pineal gland arrestin) because it is highly antigenic and can induce experimental autoimmune uveoretinitis. Mutations in the SAG gene have been associated with Oguchi disease, a rare autosomal recessive form of night blindness. The mouse ortholog is Sag.
SAG binds phosphorylated, light-activated rhodopsin and blocks transducin coupling, making it central to studies of how rod photoreceptor signalling is switched off.
S-arrestin may help protect photoreceptor cells from light-dependent degeneration, which makes it relevant to work on retinal cell survival.
Mutations in SAG are associated with Oguchi disease, a rare autosomal recessive form of night blindness, so the gene is studied in inherited retinal disorders.
S-antigen is highly antigenic and can induce experimental autoimmune uveoretinitis, so it is used to study autoimmune inflammation of the eye.
SAG, or S-arrestin, terminates phototransduction in rod photoreceptors. It binds photoactivated, phosphorylated rhodopsin and prevents its interaction with transducin (GNAT1), ending transducin-mediated opsin signalling. It may also help to prevent light-dependent degeneration of retinal photoreceptor cells.
S-antigen is the earlier name, in full S-antigen; retina and pineal gland (arrestin), reflecting the protein's expression in those tissues and its strong antigenicity. ARRESTIN and RP47 are further aliases, and the approved HGNC name is S-antigen visual arrestin. UniProt lists the protein as S-arrestin.
Mutations in SAG are associated with Oguchi disease, a rare autosomal recessive form of night blindness. S-arrestin can also induce experimental autoimmune uveoretinitis. A mouse ortholog, Sag, is listed in the data; check the datasheet of any product for its validated reactivity.
Other arrestins, rhodopsin signalling partners and retinal markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P10523; product specifications from Assay Genie datasheets.